Skip to content
Contact Us
Contact Us
  • Site License Info
  • Article Hub
  • Librarian Resources
  • Account Admin
  • Request a Quote
Tip of the Month

Select NEJM Group content now available in Chinese


August 2, 2018
Share

Did you know that three NEJM articles — including up to two original research articles — are translated into the Chinese language each week by physician-editors in China? NEJM Yi Xue Qian Yan is accessible by individuals after registering here. Readers who have a subscription to NEJM or access it through an institutional license can click on a link at the top right of select articles on NEJM.org to bring them to the Chinese translation. Additionally, the NEJM weekly table of contents is translated into Chinese and available on nejmqianyan.cn and through iOS and Android mobile apps.

The three NEJM articles chosen each week for translation focus on the areas of medicine that are of most concern in China: cancer, stroke, cardiovascular disease, diabetes, pulmonary disease, pediatrics, and maternal health. NEJM Yi Xue Qian Yan also translates articles from the 12 NEJM Journal Watch editions — specialty-specific literature reviews with added physician commentary.

Spread the word about NEJM Yi Xue Qian Yan, which makes trusted medical information from NEJM Group more accessible to native Chinese speakers.

Continue Reading

  • All Content
  • Featured Article
  • Featured Librarian
  • Tip of the Month

Be alerted when new content is posted

Sign Up
Top

My NEJM

Manage your institutional account and obtain usage reports.

Log In

Considering a site license?

Request a quote to learn more about the benefits of a site license.

Request Quote

Librarian Resources

Resources, tools and ideas to help you make the most of your site license.

Learn More
  • Site License Info
  • Article Hub
  • Librarian Resources
  • Account Admin
  • Request a Quote
Contact Us

© 2023 Copyright Massachusetts Medical Society. NEJM Group is a division of the Massachusetts Medical Society.

  • Copyright
  • Terms of Use
  • Privacy Policy
  • FAQs